Bath & Body Works (NYSE:BBWI) Price Target Raised to $25.00

Bath & Body Works (NYSE:BBWI) had its price target boosted by Wells Fargo & Company from $24.00 to $25.00 in a research note released on Thursday, Marketbeat.com reports. Wells Fargo & Company currently has an overweight rating on the stock.

A number of other brokerages have also recently commented on BBWI. Argus restated a “hold” rating on shares of Bath & Body Works in a research report on Wednesday, September 16th. Deutsche Bank Aktiengesellschaft set a $22.00 price objective on shares of Bath & Body Works in a research report on Thursday, August 27th. Robert W. Baird reduced their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating on the stock in a research note on Thursday, August 27th. Morgan Stanley reduced their price objective on shares of Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 27th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a report on Tuesday, October 6th. Four research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $22.20.

Bath & Body Works Price Performance

BBWI opened at $22.78 on Thursday. The business’s 50-day moving average price is $18.57 and its two-hundred day moving average price is $19.84. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $25.21. The company has a market capitalization of $4.59 billion, a price-to-earnings ratio of 5.93, a P/E/G ratio of 1.14 and a beta of 1.40.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. The business had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Sell-side analysts anticipate that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Friday, August 21st were given a dividend of $0.20 per share. The ex-dividend date was Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 3.5%. Bath & Body Works’s dividend payout ratio is 20.83%.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently added to or reduced their stakes in the business. Elevation Wealth Partners LLC boosted its position in shares of Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after acquiring an additional 1,742 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Bath & Body Works by 35.5% in the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after purchasing an additional 673 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Bath & Body Works in the second quarter valued at $66,000. Global Retirement Partners LLC bought a new stake in Bath & Body Works in the second quarter worth $71,000. Finally, Root Financial Partners LLC increased its position in Bath & Body Works by 4,485.7% in the first quarter. Root Financial Partners LLC now owns 3,210 shares of the company’s stock worth $60,000 after purchasing an additional 3,140 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its merchandise includes body lotions, shower gels, fragrances, soaps, hand sanitizers, candles, air fresheners and other fragrance-focused items sold under the Bath & Body Works brand.

The company operates through a network of retail stores and digital commerce channels, serving customers primarily in the United States and Canada. Its products are also available internationally through select partners, including franchise, wholesale and other distribution arrangements.

Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc The company became an independent publicly traded business in 2021 after separating from L Brands.